Clinical trials
Phase 1/2 Sarcoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Grupo Espanol de Investigacion en Sarcomas | 2 |
| Institut Bergonié | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Australasian Sarcoma Study Group | 1 |
| ImmVira Pharma Co. Ltd | 1 |
| Innolake Biopharm | 1 |
| Kantonsspital Aarau | 1 |
| Letolab | 1 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 1 |
| N.N. Petrov National Medical Research Center of Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 14 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Chondrosarcoma | 2 |
| Neoplasm Metastasis | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.